GB0310980D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0310980D0
GB0310980D0 GBGB0310980.8A GB0310980A GB0310980D0 GB 0310980 D0 GB0310980 D0 GB 0310980D0 GB 0310980 A GB0310980 A GB 0310980A GB 0310980 D0 GB0310980 D0 GB 0310980D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0310980.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidelta doo
Original Assignee
Glaxo Group Ltd
Pliva Farmaceutika dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Farmaceutika dd filed Critical Glaxo Group Ltd
Priority to GBGB0310980.8A priority Critical patent/GB0310980D0/en
Publication of GB0310980D0 publication Critical patent/GB0310980D0/en
Priority to CA002525457A priority patent/CA2525457A1/en
Priority to JP2006529796A priority patent/JP2007500193A/ja
Priority to AT04732113T priority patent/ATE450543T1/de
Priority to CL200401006A priority patent/CL2004001006A1/es
Priority to EP04732113A priority patent/EP1628990B1/en
Priority to ARP040101611A priority patent/AR044306A1/es
Priority to CNA2004800191978A priority patent/CN1816557A/zh
Priority to US10/556,706 priority patent/US20070141276A1/en
Priority to DE602004024388T priority patent/DE602004024388D1/de
Priority to PCT/EP2004/005084 priority patent/WO2004101588A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24149—Honeycomb-like
    • Y10T428/24157—Filled honeycomb cells [e.g., solid substance in cavities, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
GBGB0310980.8A 2003-05-13 2003-05-13 Novel compounds Ceased GB0310980D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0310980.8A GB0310980D0 (en) 2003-05-13 2003-05-13 Novel compounds
PCT/EP2004/005084 WO2004101588A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered ring compounds
CL200401006A CL2004001006A1 (es) 2003-05-13 2004-05-11 Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceuticas que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topic
JP2006529796A JP2007500193A (ja) 2003-05-13 2004-05-11 新規な１４−及び１５−員環化合物
AT04732113T ATE450543T1 (de) 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen
CA002525457A CA2525457A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered ring compounds
EP04732113A EP1628990B1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered ring compounds
ARP040101611A AR044306A1 (es) 2003-05-13 2004-05-11 Compuesto de macrolido de 14 y 15 eslabones sustituido en la posicion 4'', procedimiento para la preparacion del mismo, su uso para la fabricacion de un medicamento y composicion farmaceutica que lo comprende
CNA2004800191978A CN1816557A (zh) 2003-05-13 2004-05-11 新型14和15元环化合物
US10/556,706 US20070141276A1 (en) 2003-05-13 2004-05-11 Novel 14 and 15 membered ring compounds
DE602004024388T DE602004024388D1 (de) 2003-05-13 2004-05-11 Neue 14- und 15-gliedrige ringverbindungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310980.8A GB0310980D0 (en) 2003-05-13 2003-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
GB0310980D0 true GB0310980D0 (en) 2003-06-18

Family

ID=9957980

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0310980.8A Ceased GB0310980D0 (en) 2003-05-13 2003-05-13 Novel compounds

Country Status (11)

Country Link
US (1) US20070141276A1 (https=)
EP (1) EP1628990B1 (https=)
JP (1) JP2007500193A (https=)
CN (1) CN1816557A (https=)
AR (1) AR044306A1 (https=)
AT (1) ATE450543T1 (https=)
CA (1) CA2525457A1 (https=)
CL (1) CL2004001006A1 (https=)
DE (1) DE602004024388D1 (https=)
GB (1) GB0310980D0 (https=)
WO (1) WO2004101588A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007528805A (ja) * 2003-12-11 2007-10-18 エアーバス サンドイッチパネル芯材
JP2007536372A (ja) * 2004-05-06 2007-12-13 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 微生物感染症の治療に有用なカルバミン酸エステル結合マクロライド
WO2006120541A1 (en) 2005-05-10 2006-11-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ether linked macrolides useful for the treatment of microbial infections
FR2995605B1 (fr) * 2012-09-18 2014-09-19 Sanofi Sa Derives de macrolides, leur preparation et leur application therapeutique.
EP3955937A4 (en) * 2019-04-18 2023-01-18 Azura Ophthalmics Ltd. COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180654A (en) * 1978-01-03 1979-12-25 Pfizer Inc. 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
WO1990011288A1 (en) * 1989-03-28 1990-10-04 Abbott Laboratories Erythromycin derivatives
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
AU710532B2 (en) * 1996-05-07 1999-09-23 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB0025688D0 (en) * 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
CA2525457A1 (en) 2004-11-25
AR044306A1 (es) 2005-09-07
CL2004001006A1 (es) 2005-03-18
US20070141276A1 (en) 2007-06-21
EP1628990B1 (en) 2009-12-02
DE602004024388D1 (de) 2010-01-14
CN1816557A (zh) 2006-08-09
ATE450543T1 (de) 2009-12-15
EP1628990A1 (en) 2006-03-01
JP2007500193A (ja) 2007-01-11
WO2004101588A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308186D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
GB0308333D0 (en) Novel compounds
EP1596860A4 (en) NEW CONNECTIONS
GB0305426D0 (en) Novel compounds
GB0310979D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0310980D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
GB0306209D0 (en) Novel compounds
GB0300482D0 (en) Novel compounds
GB0305687D0 (en) Novel compounds
GB0305586D0 (en) Novel compounds
GB0305564D0 (en) Novel compounds
GB0305722D0 (en) Novel compounds
GB0305293D0 (en) Novel compounds
GB0305292D0 (en) Novel compounds
GB0305291D0 (en) Novel compounds
GB0305290D0 (en) Novel compounds
GB0305285D0 (en) Novel compounds
GB0305165D0 (en) Novel compounds

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: PLIVA-ISTRAZIVACKI INSTITUT D.O.O.

Free format text: FORMER APPLICANT(S): PLIVA D.D.

AT Applications terminated before publication under section 16(1)